Your biggest fear about corporate investors may also be the biggest myth
Will a corporate VC close doors for you - or will they open up?
Take the MedCity News survey on corporate venture capital in digital health
There isn't as much insight and understanding of how these investors operate
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Corporate ventures in life science are important, but generate mixed feelings
The shift in the stage of investment and where the perceived opportunities in biotech are have had a significant impact.
Read the MedCity News survey on corporate venture capital in healthcare
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
A growing problem for healthcare startups seeking investment: (Almost) no one wants to lead
OK, it's a cheap shot to call them sheep. But there are too many followers among healthcare investors.
Is the athenahealth accelerator term sheet disruptive or just awful?
Not everyone is a fan of this kind of disruption, thank you. But is the tradeoff worth it?
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medtech venture capital: Opportunistic vs. commitment styles of investment
Venture capitalists have been criticized of late for their opportunistic investing choices in medical devices – moving away from early stage investment and into safer, later-stage deals that herald larger returns. Early stage investment, dubbed commitment investing, requires that they accept a longer wait to exit. This is all but dying out in medical device venture capital – making it harder […]
From corporate venture and beyond: How healthcare startups find fund-raising success
Read this in-the-trenches view of fund-raising for life science companies. How has the landscape changed? And how can you better protect yourself as you start talking about your proprietary ideas to grant committee and big corporations? Find out who an entrepreneur's biggest ally is when they are doing healthcare fund-raising.
Friday is the deadline for you to shape how healthcare looks at corporate venture capital
We're reaching the finish line on MedCity News' survey on investing and corporate venture capital. Our deadline is Friday, so please take the survey and share your thoughts on the life science corporate VCs you know and have dealt with, as well as what your thoughts are on the modern environment for fund-raising in the life sciences.
Which are the best life science corporate VCs? Take MedCity News’ survey
We need your help in getting better information on life science corporate venture capital funds. Will you share your thoughts on corporate VCs as well as the state of life science investing in general?
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Google Ventures GP highlights complexities of using digital health to help disadvantaged patients
Given Google Ventures’ profile in healthcare investment, the companies it chooses to back make folks sit up and take notice. In a rare talk, Google Ventures General Partner Dr. Krishna Yeshwant shared some of the things that inform its investment choices and others what constrain them. MobiHealthNews highlighted the talk at the Hx Refactored conference in […]
Emerging sources of early-stage life science funding embrace the role of ‘venture catalysts’
It was nice to hear one healthcare executive and investor after another respond to the question, “what are your key priorities when evaluating a deal?” with the answer, “really compelling science.” I’ve often heard VCs and angel investors cite the importance of large addressable markets and talented executive teams as key considerations to a deal, […]
Sigh. Healthcare corporate venture capital investments hit five-quarter low in Q3
Corporate venture capital investments in healthcare hit a five-quarter low in Q3, down in both deals and funding, according to a new report out from CB Insights. Compared to the quarter before, deals and funding decreased by 41 percent and 27 percent respectively. The tried-and-true players fared well: California, Massachusetts and Minnesota grabbed the CVC […]
Here’s a look at healthcare’s top 10 corporate investors and acquirers
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really taken off over the last few years as pharma and medical device companies have opened their doors and wallets to find innovation outside of their four walls. A new analysis from […]
Q2 Corporate VC healthcare deals, funding both up more than 30 percent
Corporate venture capital may be what fills in the large gaps VC has left behind, with CVC deals about 60 percent larger than VC deals on the whole. Healthcare corporate venture capital deals are up nearly 40 percent compared to Q1 and funding is up 34 percent, according to a report from CB Insights. There were […]